Yousif Capital Management LLC Sells 8,551 Shares of GE HealthCare Technologies Inc. $GEHC

Yousif Capital Management LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.9% in the 3rd quarter, Holdings Channel reports. The firm owned 52,938 shares of the company’s stock after selling 8,551 shares during the quarter. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $3,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of GEHC. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after acquiring an additional 703,903 shares during the period. Dodge & Cox grew its stake in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. State Street Corp raised its holdings in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after buying an additional 372,755 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after buying an additional 231,302 shares during the period. Finally, Norges Bank acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at $468,120,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC opened at $83.29 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market capitalization of $37.94 billion, a P/E ratio of 17.21, a price-to-earnings-growth ratio of 3.48 and a beta of 1.10. The company’s 50 day simple moving average is $78.55 and its 200-day simple moving average is $75.73. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Stifel Nicolaus set a $90.00 price objective on GE HealthCare Technologies in a research note on Friday, November 21st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday. Barclays started coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, Jefferies Financial Group raised their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $87.09.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.